Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events
Authors:
- Erin D. MichosEMErin D. Michos
- Christopher T. SibleyCSChristopher T. Sibley
- Jefferson T. BaerJBJefferson T. Baer
- Michael J. BlahaMBMichael J. Blaha
- Roger S. BlumenthalRBRoger S. Blumenthal
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Novel HDL-directed pharmacotherapeutic strategiesNature Reviews Cardiology, 2011
- Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisAtherosclerosis, 2010
- Extended-Release Niacin or Ezetimibe and Carotid Intima–Media ThicknessNew England Journal of Medicine, 2009
- Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular FunctionJACC, 2009
- Of Mice and MenArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- The effect of 24 months of combination statin and extended-release niacin on carotid intima‐media thickness: ARBITER 3Current Medical Research and Opinion, 2006
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary DiseaseNew England Journal of Medicine, 2001
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJACC, 1986